A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

Oprah Winfrey said taking weight-loss drugs, like Ozempic and Wegovy, helped her realize the truth about 'thin people.' ...

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger people? Katharine Lang reports Obesity in children and adolescents is a ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

The rise in popularity of anti-obesity medications (AOMs), such as popular brand names Ozempic and Wegovy could see a shift ...

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...

Oprah Winfrey shares her transformative weight-loss journey with GLP-1 medications, challenging societal perceptions of willpower and obesity in a candid podcast conversation with Dr. Ania Jastreboff.

In a discussion with Oprah, Dr Ania called obesity a disease. She also advised that we should treat obesity like other ...